Aditxt acquires Ignite Proteomics to enhance cancer therapy selection

NASA awards Redwire USD4m to advance drug development in microgravity

Elicera Therapeutics receives Japanese patent allowance for ELC-401 CAR T-cell candidate

Curatis and Neupharma partner to develop corticorelin for peritumoral brain edema in Japan

Citius Oncology reports positive topline results from Phase 1 clinical trial of LYMPHIR combination

GenomOncology partners with WeTrials to support CNS cancer clinical trials

Agenus triggers USD20m milestone payment under Zydus manufacturing collaboration

AstraZeneca and Daiichi Sankyo's Enhertu receives US priority review for post-neoadjuvant HER2-positive early breast cancer

Zelluna partners with Etcembly to advance AI-driven TCR engineering for solid tumours

IDEAYA Biosciences enrols first patient in Phase 1 trial of PRMT5 inhibitor IDE892

Servier signs definitive agreement with Day One Biopharmaceuticals

Foresee Pharmaceuticals receives positive CHMP opinion for CAMCEVI 21 mg

Great Novel Therapeutics' GNTbm-38 approved by US FDA for Phase I trial

Elicera Therapeutics reports complete metabolic responses in highest‑dose CARMA cohort

Akeso agrees clinical trial collaboration with INOVIO